UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000042441 |
|---|---|
| Receipt number | R000048427 |
| Scientific Title | Epidemic research to assess health disparities |
| Date of disclosure of the study information | 2020/11/16 |
| Last modified on | 2020/11/13 11:26:49 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Research to assess health disparities
Acronym
Research about health disparities
Scientific Title
Epidemic research to assess health disparities
Scientific Title:Acronym
Epidemic research about health disparities
Region
| Japan |
Condition
Condition
Healthy controls, allergic diseases, et cetera.
Classification by specialty
| Medicine in general | Pneumology | Clinical immunology |
| Pediatrics | Child |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To assess health disparities
Basic objectives2
Others
Basic objectives -Others
To assess health disparities in infancy and childhood
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Health disparities
Key secondary outcomes
The relationship between clinical factors and diseases including allergic diseases in infancy and childhood.
The relationship between allergic rhinitis, asthma, and atopic dermatitis.
The relationship between first milk and allergic diseases, etc.
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 1 | years-old | <= |
Age-upper limit
| 16 | years-old | > |
Gender
Male and Female
Key inclusion criteria
Children born in 2001 and 2010
Key exclusion criteria
Those who do not consent with this study.
Target sample size
80000
Research contact person
Name of lead principal investigator
| 1st name | Takahiro |
| Middle name | |
| Last name | Tabuchi |
Organization
Osaka International Cancer Institute
Division name
Cancer Control Center
Zip code
541-8567
Address
1-69, Ohtemae 3-Chome, Chuo-ku, Osaka, 541-8567 Japan
TEL
+81-6-6945-1181
tabuchitak@gmail.com
Public contact
Name of contact person
| 1st name | Takahiro |
| Middle name | |
| Last name | Tabuchi |
Organization
Osaka International Cancer Institute
Division name
Cancer Control Center
Zip code
541-8567
Address
1-69, Ohtemae 3-Chome, Chuo-ku, Osaka, 541-8567 Japan
TEL
+81-6-6945-1181
Homepage URL
tabuchitak@gmail.com
Sponsor or person
Institute
Osaka International Cancer Institute
Institute
Department
Personal name
Funding Source
Organization
Ministry of education, culture, sports, science and technology
Organization
Division
Category of Funding Organization
Japanese Governmental office
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Osaka International Cancer Institute
Address
1-69, Ohtemae 3-Chome, Chuo-ku, Osaka, 541-8567 Japan
Tel
+81-6-6945-1181
rinri01@opho.jp
Secondary IDs
Secondary IDs
YES
Study ID_1
1508119060
Org. issuing International ID_1
Osaka International Cancer Institute
Study ID_2
1508119060-2
Org. issuing International ID_2
Osaka International Cancer Institute
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2020 | Year | 11 | Month | 16 | Day |
Related information
URL releasing protocol
Publication of results
Partially published
Result
URL related to results and publications
Number of participants that the trial has enrolled
85564
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
No longer recruiting
Date of protocol fixation
| 2000 | Year | 07 | Month | 15 | Day |
Date of IRB
| 2015 | Year | 01 | Month | 08 | Day |
Anticipated trial start date
| 2001 | Year | 01 | Month | 01 | Day |
Last follow-up date
| 2024 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Observational study
Management information
Registered date
| 2020 | Year | 11 | Month | 13 | Day |
Last modified on
| 2020 | Year | 11 | Month | 13 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048427
